seed
Stage
2
Investors
About
Thelior Bio develops targeted biologic treatments for long-term management of inflammatory bowel conditions, focusing on restoring gut lining integrity using monoclonal molecules to block tissue-damaging signals identified through patient-derived molecular research.
Explore Thelior Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.